CCO Expert Recap

Update on First-Line Therapy and Switch Strategies

Source: CCO Independent Conference Coverage of the 2008 Conference on Retroviruses and Opportunistic Infections*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Update on First-Line Therapy and Switch Strategies

Faculty:

Kathleen E. Squires, MD
Andrew Carr, MBBS, MD, FRACP, FRCP
Judith S. Currier, MD, MSc

Eric S. Daar, MD
Joseph J. Eron, Jr., MD
Joel E. Gallant, MD, MPH

W. David Hardy, MD
Sally Hodder, MD
Donald P. Kotler, MD

William G. Powderly, MD
Andrew R. Zolopa, MD

CME CREDIT INFORMATION

Release Date: 03/26/08

Expiration Date: 03/25/09

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.2 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss new findings regarding the effects of delaying or interrupting antiretroviral therapy
Describe new data from randomized studies comparing different boosted PIs and different NRTI backbones in first-line antiretroviral therapy
Cite new insights regarding cardiovascular risks associated with antiretroviral therapy
Recount new findings regarding the use of antiretroviral therapy in prevention of mother-to-child HIV transmission

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.